Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening. Blood 2010 Dec 02;116(23):5050-9

Date

08/04/2010

Pubmed ID

20679525

Pubmed Central ID

PMC3012599

DOI

10.1182/blood-2010-04-281154

Scopus ID

2-s2.0-78649747986 (requires institutional sign-in at Scopus site)   101 Citations

Abstract

The platelet integrin α(IIb)β(3) is essential for hemostasis and thrombosis through its binding of adhesive plasma proteins. We have determined crystal structures of the α(IIb)β(3) headpiece in the absence of ligand and after soaking in RUC-1, a novel small molecule antagonist. In the absence of ligand, the α(IIb)β(3) headpiece is in a closed conformation, distinct from the open conformation visualized in presence of Arg-Gly-Asp (RGD) antagonists. In contrast to RGD antagonists, RUC-1 binds only to the α(IIb) subunit. Molecular dynamics revealed nearly identical binding. Two species-specific residues, α(IIb) Y190 and α(IIb) D232, in the RUC-1 binding site were confirmed as important by mutagenesis. In sharp contrast to RGD-based antagonists, RUC-1 did not induce α(IIb)β(3) to adopt an open conformation, as determined by gel filtration and dynamic light scattering. These studies provide insights into the factors that regulate integrin headpiece opening, and demonstrate the molecular basis for a novel mechanism of integrin antagonism.

Author List

Zhu J, Zhu J, Negri A, Provasi D, Filizola M, Coller BS, Springer TA

Author

Jieqing Zhu PhD Professor in the Biochemistry department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Binding Sites
Fibrinogen
Humans
Mutagenesis, Site-Directed
Platelet Glycoprotein GPIIb-IIIa Complex
Protein Binding
Protein Conformation
X-Ray Diffraction